Reinhard J. Ambros's most recent trade in Rein Therapeutics Inc. was a trade of 35,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 2, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rein Therapeutics Inc. | Reinhard J. Ambros | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Rein Therapeutics Inc. | Reinhard J. Ambros | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2024 | 2,725 | 2,725 | - | - | Stock Option (right to buy) | |
| Rein Therapeutics Inc. | J. Reinhard Ambros | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 2,725 | 2,725 | - | - | Stock Option (right to buy) | |
| Rein Therapeutics Inc. | Reinhard J. Ambros | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 2,725 | 2,725 | - | - | Stock Option (right to buy) | |
| Rein Therapeutics Inc. | Reinhard J. Ambros | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 96,000 | 96,000 | - | - | Stock Option (right to buy) |